Pharmaceutical and Biotechnology major, Wockhardt today swung to profit for the third quarter ended Dec. 2010. The company reported a consolidated profit of Rs 1.42 billion as against the loss of Rs 1.81 billion reported the previous quarter. Meanwhile, consolidated total income for the quarter rose 6.90% to Rs 9.51 billion, when compared with the prior year period.

``Our operations remain strong and have consistently shown growth in EBIDTA and EBIDTA margins during the current year,`` said Wockhardt Chairman Dr. Habil Khorakiwala. He further added that EBIDTA has grown by 82% and EBIDTA margin is at 25.6%.

The stock had outperformed the market over the past one month till Feb. 02, 2011, rising 0.12% compared with the Sensex`s 11.79% decline. It outperformed the market in past one quarter, gaining 20.19% as against 11.08% fall in the Sensex.

Shares of the company gained Rs 14.3, or 3.92%, to settle at Rs 379.45. The total volume of shares traded was 47,721 at the BSE (Wednesday).